During the past decade, UPMC Jefferson Regional Radiation Oncology conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 23 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 21 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Jefferson Regional Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Jefferson Regional Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Jefferson Regional Radiation Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage II Breast Cancer" (3 trials) and "Stage IIIC Breast Cancer" (3 trials). Many other conditions were trialed in "UPMC Jefferson Regional Radiation Oncology" in a lesser frequency.

Most popular intervention types in "UPMC Jefferson Regional Radiation Oncology" are "Drug" (37 trials), "Other" (33 trials), "Biological" (17 trials), "Radiation" (12 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (10 trials), "Cisplatin" (9 trials), "Docetaxel" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Jefferson Regional Radiation Oncology" are 33 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Jefferson Regional Radiation Oncology". undefined are not yet recruiting, 7 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in UPMC Jefferson Regional Radiation Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Jefferson Regional Radiation Oncology, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".